Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP5524.RAbUuS05kZ4aaqY61uPNlll9u3Nk4S9cJbaKZeJzIRxMY#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 15621812 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Imatinib, the ABL kinase inhibitor, is used not only for Philadelphia chromosome-positive (Ph + ) chronic myelogenous leukemia, but also for Ph + acute lymphoblastic leukemia (ALL), although resistance to the drug tends to develop in an early stage of the clinical course.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.